TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 26469827

Group type: EXPERIMENTAL
Intervention: Sacubitril-valsartan (combination drug containing sacubitril and valsartan)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Enalapril (angiotensin-converting enzyme inhibitor)
Number of subjects: 0
Study: 23946212

Group type: EXPERIMENTAL
Intervention: Deferasirox
Number of subjects: 203

Group type: COMPARATOR
Intervention: Deferoxamine (DFO)
Number of subjects: 203

Group type: EXPERIMENTAL
Intervention: Deferasirox with concomitant hydroxyurea
Number of subjects: 203
Study: 21811939

Group type: EXPERIMENTAL
Intervention: Narrow band imaging (NBI)
Number of subjects: 22

Group type: COMPARATOR
Intervention: High resolution endoscopy (HRE)
Number of subjects: 22
Study: 19719452

Group type: EXPERIMENTAL
Intervention: Single vaccination with modified-live respiratory virus vaccine
Number of subjects: 612

Group type: EXPERIMENTAL
Intervention: Revaccination with modified-live respiratory virus vaccine
Number of subjects: 612

Group type: COMPARATOR
Intervention: Control group (no vaccine during finishing phase)
Number of subjects: 612
Study: 16698351

Group type: EXPERIMENTAL
Intervention: Activated TENS
Number of subjects: 148

Group type: COMPARATOR
Intervention: Placebo TENS
Number of subjects: 148

Group type: COMPARATOR
Intervention: Control (no analgesics)
Number of subjects: 148
Study: 15604849

Group type: EXPERIMENTAL
Intervention: Drug-eluting stents
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sirolimus-eluting stents
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nontoxic systemic drugs
Number of subjects: 0
Study: 11309833

Group type: EXPERIMENTAL
Intervention: Plasma exchange treatment administered every other day for 2 weeks
Number of subjects: 22

Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Crossover to active treatment after failing sham treatment
Number of subjects: 22

Group type: COMPARATOR
Intervention: Crossover to sham treatment after failing active treatment
Number of subjects: 22
Study: 9407564

Group type: EXPERIMENTAL
Intervention: Inhaled nitric oxide (NO) at concentrations of 1, 5, 10, and 20 parts per million (ppm)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo (0 ppm NO)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Inhaled nitric oxide (NO)
Number of subjects: 11
Study: 7712700

Group type: EXPERIMENTAL
Intervention: Standard 75 g oral glucose tolerance test (OGTT)
Number of subjects: 1122
Study: 2575550

Group type: EXPERIMENTAL
Intervention: Somatostatin (SST)
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Ranitidine
Number of subjects: 220

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 220
Study: 855911

Group type: EXPERIMENTAL
Intervention: Adrenaline 350 microng
Number of subjects: 0

Group type: COMPARATOR
Intervention: POR 8 5.5 IU
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 0
Study: 31789899

Group type: EXPERIMENTAL
Intervention: 250 ml of tea with milk
Number of subjects: 50

Group type: COMPARATOR
Intervention: 250 ml of water
Number of subjects: 50
Study: 31577341

Group type: EXPERIMENTAL
Intervention: Abrocitinib 200 mg
Number of subjects: 267

Group type: EXPERIMENTAL
Intervention: Abrocitinib 100 mg
Number of subjects: 267

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 267
Study: 28677826

Group type: EXPERIMENTAL
Intervention: Elotuzumab + lenalidomide/dexamethasone (ELd)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Lenalidomide/dexamethasone (Ld)
Number of subjects: 0
Study: 25581661

Group type: EXPERIMENTAL
Intervention: Drink-EtOH adjustments using transdermal alcohol sensor (TAS) readings and self-reported diaries.
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Drink-EtOH adjustment ratios (EtOH adjusted/unadjusted amounts).
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Degree of adjustment controlling for raw number of drinks and other covariates.
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Higher correlations between adjusted versus raw drinks/event and TAS areas under the curve.
Number of subjects: 220
Study: 21672300

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioural Therapy (CBT)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Relaxation Training (RT)
Number of subjects: 70
Study: 20587028

Group type: EXPERIMENTAL
Intervention: Cryotherapy (n = 309)
Number of subjects: 612

Group type: COMPARATOR
Intervention: Control group (n = 303)
Number of subjects: 612

Group type: EXPERIMENTAL
Intervention: HIV-positive women (n = 72)
Number of subjects: 612
Study: 18071056

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (cumulative dose, 0.4 μg/kg)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 73
Study: 15910204

Group type: EXPERIMENTAL
Intervention: Extended-release mixed amphetamine salts (MAS-XR) 10-30 mg doses
Number of subjects: 568
Study: 12790363

Group type: EXPERIMENTAL
Intervention: Acetazolamide (ACZ) 1000 mg injection
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo (distilled water)
Number of subjects: 30
Study: 10503804

Group type: EXPERIMENTAL
Intervention: Blinded assessment of the Jadad scale
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Unblinded assessment of the Jadad scale
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Blinded assessment with removal of the third item (withdrawals)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Effect of blinding on Jadad scale scores
Number of subjects: 76
Study: 7773118

Group type: EXPERIMENTAL
Intervention: Teachers' administration of questionnaires
Number of subjects: 3017

Group type: COMPARATOR
Intervention: Researchers' administration of questionnaires
Number of subjects: 3017
Study: 1972557

Group type: EXPERIMENTAL
Intervention: Inhaled salbutamol (800 micrograms)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Inhaled pirbuterol (800 micrograms)
Number of subjects: 8
Study: 387057

Group type: EXPERIMENTAL
Intervention: MK-196 (10 mg daily)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: MK-196 (15 mg daily)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Hydrochlorothiazide (HCT; 50 mg daily)
Number of subjects: 42
Study: 30447510

Group type: EXPERIMENTAL
Intervention: Parents under Pressure (PuP) program
Number of subjects: 115

Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 115
Study: 29469081

Group type: EXPERIMENTAL
Intervention: Statins
Number of subjects: 65196

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 65196
Study: 26503347

Group type: EXPERIMENTAL
Intervention: SoluMatrix meloxicam 5mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: SoluMatrix meloxicam 10mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 23552356

Group type: EXPERIMENTAL
Intervention: Sublingual melatonin 3 mg
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 20705718

Group type: EXPERIMENTAL
Intervention: Low-dose hCG
Number of subjects: 0

Group type: COMPARATOR
Intervention: rFSH plus GnRH antagonist
Number of subjects: 0
Study: 19930615

Group type: EXPERIMENTAL
Intervention: Resilience training program (READY) with physical activity promotion
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Resilience training program (READY) without physical activity promotion
Number of subjects: 95

Group type: COMPARATOR
Intervention: Control group (waitlist)
Number of subjects: 95
Study: 16814744

Group type: EXPERIMENTAL
Intervention: Cognitive Behavior Therapy (CBT)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control program (placebo)
Number of subjects: 90
Study: 15257812

Group type: EXPERIMENTAL
Intervention: Triptorelin 0.1 mg (group 1)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Triptorelin 0.1 mg (group 2)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Triptorelin 0.5 mg (group 3)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Triptorelin 0.1 mg three times (group 4)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Oral micronized progesterone (group 5)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Human chorionic gonadotrophin (HCG) 1500 IU (group 6)
Number of subjects: 0
Study: 11166518

Group type: EXPERIMENTAL
Intervention: Apomorphine (APO), 0.01 mg/kg
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Antipsychotic drug treatment
Number of subjects: 98
Study: 9154767

Group type: EXPERIMENTAL
Intervention: Thalidomide (200 mg orally once per day for four weeks)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Placebo (orally once per day for four weeks)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Thalidomide
Number of subjects: 57
Study: 8227504

Group type: EXPERIMENTAL
Intervention: Clinician administered treatment
Number of subjects: 12

Group type: COMPARATOR
Intervention: Combination of clinician administered treatment and parent administered instruction with the Speech Viewer system
Number of subjects: 12
Study: 2900682

Group type: EXPERIMENTAL
Intervention: progabide
Number of subjects: 33

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 33
Study: 29532525

Group type: EXPERIMENTAL
Intervention: Deproteinized bone mineral with a collagen membrane
Number of subjects: 27

Group type: COMPARATOR
Intervention: Collagen membrane only
Number of subjects: 27
Study: 27397824

Group type: EXPERIMENTAL
Intervention: Nurse-led cognitive-behavioral intervention program (12 weeks)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Traditional care (control group)
Number of subjects: 100
Study: 24602844

Group type: EXPERIMENTAL
Intervention: Early antiretroviral treatment
Number of subjects: 1763

Group type: COMPARATOR
Intervention: Delayed antiretroviral treatment
Number of subjects: 1763
Study: 22949223

Group type: EXPERIMENTAL
Intervention: Abatacept (ABA)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Methotrexate (MTX)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 99
Study: 20493485

Group type: EXPERIMENTAL
Intervention: CO(2) insufflation
Number of subjects: 74

Group type: COMPARATOR
Intervention: Air insufflation
Number of subjects: 74
Study: 17766190

Group type: EXPERIMENTAL
Intervention: Intravenous meropenem (120 mg/kg/day) and intravenous tobramycin (9-12 mg/kg/day)
Number of subjects: 118

Group type: COMPARATOR
Intervention: Intravenous ceftazidime (200-400 mg/kg/day) and intravenous tobramycin (9-12 mg/kg/day)
Number of subjects: 118
Study: 16741879

Group type: EXPERIMENTAL
Intervention: ART
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Baseline CD4+ and CD8+ T cell activation
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: High memory (CDRA(‐)CD62L‐) CD8+ T cell counts at baseline
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Increased naive CD4+ T cell counts
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Cell-associated HIV-1 DNA level at baseline
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Cell-associated HIV-1 DNA level at week 48 of ART
Number of subjects: 116
Study: 12826839

Group type: EXPERIMENTAL
Intervention: Narcotrend monitoring
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: BIS monitoring
Number of subjects: 120

Group type: COMPARATOR
Intervention: Standard anesthetic practice
Number of subjects: 120
Study: 10813122

Group type: EXPERIMENTAL
Intervention: Laparoscopic ultrasonography
Number of subjects: 77

Group type: COMPARATOR
Intervention: Intraoperative ultrasonography with bimanual liver palpation
Number of subjects: 77

Group type: COMPARATOR
Intervention: Contrast-enhanced computerized tomography (CT)
Number of subjects: 77
Study: 8978441

Group type: EXPERIMENTAL
Intervention: Difficult mental calculation task
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sternberg paradigm with a memory set of 5 or 3 digits
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control stimulus with the same physical characteristics as the arithmetical symbols
Number of subjects: 0
Study: 1452593

Group type: EXPERIMENTAL
Intervention: Distraction therapy using videos during burn dressing changes
Number of subjects: 17
Study: 6711270

Group type: COMPARATOR
Intervention: 40 ml of 1% mepivacaine with adrenaline 1:200,000
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 50 ml of 1% mepivacaine with adrenaline 1:200,000
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 60 ml of 1% mepivacaine with adrenaline 1:200,000
Number of subjects: 90
Study: 31204396

Group type: EXPERIMENTAL
Intervention: Glass-ionomer sealants with acid pretreatment
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Resin-based sealants with acid pretreatment
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Teeth treated with air abrasion and acid etching
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Fissure depth
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Enamel surface preparation protocols
Number of subjects: 90
Study: 29855172

Group type: EXPERIMENTAL
Intervention: ABT-122 60 mg every other week
Number of subjects: 222

Group type: EXPERIMENTAL
Intervention: ABT-122 120 mg every other week
Number of subjects: 222

Group type: EXPERIMENTAL
Intervention: ABT-122 120 mg every week
Number of subjects: 222

Group type: COMPARATOR
Intervention: Adalimumab 40 mg every other week
Number of subjects: 222
Study: 26350429

Group type: EXPERIMENTAL
Intervention: Print educational intervention
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Digital educational intervention
Number of subjects: 103
Study: 23689963

Group type: EXPERIMENTAL
Intervention: Posterior-stabilized TKA
Number of subjects: 40

Group type: COMPARATOR
Intervention: Cruciate-retaining TKA
Number of subjects: 40
Study: 22750961

Group type: EXPERIMENTAL
Intervention: SaeboFlex orthosis training for 1 hour per day, 5 times per week for 4 weeks
Number of subjects: 10

Group type: COMPARATOR
Intervention: SaeboFlex orthosis (control group) for 1 hour per day without training
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: SaeboFlex orthosis training
Number of subjects: 10
Study: 19347946

Group type: EXPERIMENTAL
Intervention: Pulsed CO2 laser at 9.3 μm, 25 or 50 Hz, 20 J/cm2 for 3,000 pulses (36 J) with water cooling
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Pulsed CO2 laser at 9.3 μm, 25 or 50 Hz, 20 J/cm2 for 3,000 pulses (36 J) without water cooling
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control group with no treatment
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control group with a small cut made with a conventional high-speed hand-piece
Number of subjects: 29
Study: 17488511

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioural Therapy (CBT) in addition to managed care, consisting of three to six individual sessions of 30 minutes each.
Number of subjects: 194

Group type: COMPARATOR
Intervention: Managed care only (Control group).
Number of subjects: 194

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioural Therapy (CBT) in addition to managed care.
Number of subjects: 194
Study: 15036181

Group type: EXPERIMENTAL
Intervention: Dual-transducer ultrasound technique measuring mean ultrasound propagation speed of the cortical and cancellous layers at the tibia shaft.
Number of subjects: 18
Study: 11641740

Group type: EXPERIMENTAL
Intervention: Rapeseed oil-based diet (RO)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control diet (SAT)
Number of subjects: 19
Study: 9533384

Group type: EXPERIMENTAL
Intervention: Errorless learning method
Number of subjects: 0

Group type: COMPARATOR
Intervention: Errorful learning method
Number of subjects: 0
Study: 8304656

Group type: EXPERIMENTAL
Intervention: Selective digestive decontamination using polymyxin E, tobramycin, and amphotericin B
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Selective digestive decontamination
Number of subjects: 80
Study: 2707527

Group type: EXPERIMENTAL
Intervention: Hydrocortisone intravenous (HC i.v.: 100 mg)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Hydrocortisone local (HC L: 100 mg)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: 5-aminosalicylic acid (5-ASA: 4 g)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Sucralfate (S: 1 g)
Number of subjects: 17
Study: 29382794

Group type: EXPERIMENTAL
Intervention: Helmet CPAP
Number of subjects: 16

Group type: COMPARATOR
Intervention: Nasal Prong CPAP
Number of subjects: 16
Study: 27056648

Group type: EXPERIMENTAL
Intervention: Tolvaptan 15mg for 5 days
Number of subjects: 51

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study: 25593103

Group type: EXPERIMENTAL
Intervention: HPV-16/18 vaccine in Arm A (90% of participating girls and boys)
Number of subjects: 32175

Group type: EXPERIMENTAL
Intervention: HPV-16/18 vaccine in Arm B (90% of girls) and HBV vaccine for boys
Number of subjects: 32175

Group type: COMPARATOR
Intervention: HBV vaccine in Arm C (all participants)
Number of subjects: 32175
Study: 23594918

Group type: EXPERIMENTAL
Intervention: Social norms marketing campaign
Number of subjects: 3800

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 3800
Study: 20724955

Group type: EXPERIMENTAL
Intervention: Single dose of hepatitis B vaccine
Number of subjects: 1478

Group type: COMPARATOR
Intervention: Preimmunization
Number of subjects: 1478
Study: 18543105

Group type: EXPERIMENTAL
Intervention: Training in parental responsiveness, developmental knowledge, and loving touch
Number of subjects: 0
Study: 15936605

Group type: EXPERIMENTAL
Intervention: Adenosine 50 microg/kg/min
Number of subjects: 2118

Group type: EXPERIMENTAL
Intervention: Adenosine 70 microg/kg/min
Number of subjects: 2118

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2118

Group type: EXPERIMENTAL
Intervention: Pooled adenosine group
Number of subjects: 2118
Study: 12749125

Group type: EXPERIMENTAL
Intervention: PGE1 cream
Number of subjects: 42
Study: 10582989

Group type: EXPERIMENTAL
Intervention: Recombinant tissue plasminogen activator
Number of subjects: 615

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 615

Group type: EXPERIMENTAL
Intervention: Not specified
Number of subjects: 615
Study: 8572357

Group type: EXPERIMENTAL
Intervention: Propofol 2 mg.kg‐1 given 2 min before desflurane increase
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Propofol 2 mg.kg‐1 given 5 min before desflurane increase
Number of subjects: 5

Group type: COMPARATOR
Intervention: No propofol pretreatment
Number of subjects: 5
Study: 1656853

Group type: EXPERIMENTAL
Intervention: Tazobactam (500 mg) administered alone
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Tazobactam (500 mg) coadministered with piperacillin (4 g)
Number of subjects: 6
Study: 6799266

Group type: EXPERIMENTAL
Intervention: Bromocriptin (30-40 mg daily)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Bromocriptin
Number of subjects: 40
Study: 31086222

Group type: EXPERIMENTAL
Intervention: Iranian propolis (1000 mg/day)
Number of subjects: 94
Study: 28484908

Group type: EXPERIMENTAL
Intervention: TT technique (group A)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: OI technique (group B)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control (group A)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control (group B)
Number of subjects: 40
Study: 25491475

Group type: EXPERIMENTAL
Intervention: Unipolar resectoscope
Number of subjects: 70

Group type: COMPARATOR
Intervention: Bipolar resectoscope
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 70
Study: 23813419

Group type: EXPERIMENTAL
Intervention: Partial submandibular gland (SMG) transplantation
Number of subjects: 39

Group type: COMPARATOR
Intervention: Total submandibular gland (SMG) transplantation
Number of subjects: 39
Study: 21114416

Group type: EXPERIMENTAL
Intervention: Aleglitazar 300 μg
Number of subjects: 44

Group type: COMPARATOR
Intervention: Atorvastatin 80 mg
Number of subjects: 44

Group type: COMPARATOR
Intervention: Rosuvastatin 40 mg
Number of subjects: 44
Study: 19181690

Group type: EXPERIMENTAL
Intervention: Sad mood and activation of old age schema
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Combination of sad mood and old age schema
Number of subjects: 71
Study: 16000582

Group type: EXPERIMENTAL
Intervention: 1-hour infusion of 100 mg/m2 paclitaxel (Taxol)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 3-hour infusion of 100 mg/m2 paclitaxel (Taxol)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Paclitaxel exposure
Number of subjects: 24
Study: 14519751

Group type: EXPERIMENTAL
Intervention: MVP group (mitomycin C 8 mg/m2 on day 1, vindesine 3 mg/m2 on days 1 and 8, cisplatin 100 mg/m2 on day 1 every 3 weeks for three cycles)
Number of subjects: 1209

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 1209
Study: 10657575

Group type: EXPERIMENTAL
Intervention: Omacor (4 capsules daily providing 3.4 g EPA+DHA per day)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Omacor
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 8866593

Group type: EXPERIMENTAL
Intervention: Theophylline
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study: 2071554

Group type: EXPERIMENTAL
Intervention: Phenytoin (100 mg po bid for adults and 50 mg po bid for children)
Number of subjects: 190
Study: 6219074

Group type: EXPERIMENTAL
Intervention: 0.5% thymoxamine
Number of subjects: 25

Group type: COMPARATOR
Intervention: 1% epinephrine
Number of subjects: 25
Study: 31643128

Group type: EXPERIMENTAL
Intervention: Prospective opioid reduction intervention (discharge sheet, nursing education, standardized prescribing guideline)
Number of subjects: 443

Group type: EXPERIMENTAL
Intervention: Prospective opioid reduction intervention
Number of subjects: 443

Group type: EXPERIMENTAL
Intervention: Post-Intervention cohort
Number of subjects: 443
Study: 31251545

Group type: EXPERIMENTAL
Intervention: Subdermal injection
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Supraperiosteal injection
Number of subjects: 36
Study: 29379800

Group type: COMPARATOR
Intervention: AIC group
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: LRCP+BFSC group
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: AIC+BFSC group
Number of subjects: 10
Study: 25786679

Group type: EXPERIMENTAL
Intervention: TAP block with 20 ml bupivacaine 0.25% with adrenaline 5 μg/ml bilaterally
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group with normal saline 20 ml bilaterally in the TAP
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: TAP block
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group with wound infiltration
Number of subjects: 60